The retention and secondary use of residual newborn screening (NBS) dried blood samples without parental consent has generated controversy and resulted in lawsuits against health departments in Texas, Minnesota, and Indiana. This manuscript summarizes the legal issues raised in the litigation and highlights additional parental concerns. The abstract can be viewed here.